Intravenous ketorolac vs NSAIDs
Number of participants reporting an adverse event · adults (mean study ages 23 to 67 years) with acute postoperative pain after abdominal/pelvic, dental or orthopedic surgeries
Intravenous ketorolac showed no clear difference in number of participants reporting any adverse event compared with another NSAID (moderate certainty).
1 finding from 1 review
- Single‐dose intravenous ketorolac for acute postoperative pain in adults 2021 · Cochrane Headline outcomes onlyRR 1.11 [1, 1.23]5 studies · 516 participantsModerate